Meta-analysis of dioxin cancer dose response for three occupational cohorts

Environmental Health Perspectives

Volumn 111, Issue 5, 2003, Pages 681-687

  Crump, Kenny S ^a   Canady, Richard ^b   Kogevinas, Manolis ^c  

^a ENVIRON INTERNATIONAL CORPORATION   (United States)

^b US Food and Drug Aministration   (United States)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Carcinogen; Dioxin; Dose response assessment; Meta analysis; Occupational cohorts

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ARTICLE; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL PROTECTION; HUMAN; LIFESPAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MEASUREMENT; META ANALYSIS; OCCUPATIONAL CANCER; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 0038106219     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.5831     Document Type: Article

References (20)

1. Aylward LL, Hays SM, Karch NJ, Paustenbach DJ. 1996. Relative susceptibility of animals and humans to the cancer hazard posed by 2,3,7,8-tetrachlorodibenzo-p-dioxin using internal measures of dose. Environ Sci Technol 30:3534-3543.
2. Becher H, Steindorf K, Flesh-Janys D. 1998. Quantitative cancer risk assessment for dioxins using an occupational cohort. Environ Health Perspect 106(suppl 2):663-670.
3. Carrier G, Brunet RC, Brodeur J. 1995. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissue. Toxicol Appl Pharmacol 131:253-266.
4. Crump KS. 1994. Risk of benzene-induced leukemia: a sensitivity analysis of the Pliofilm cohort with additional follow-up and new exposure estimates. J Toxicol Environ Health 42:219-242.
5. Crump KS. 1995. Calculation of benchmark doses from continuous data. Risk Anal 15:79-89.
6. Fingerhut M, Halperin WE, Marlow DA, Piacitelli LA, Houchar PA, Sweeney MH, et al. 1991. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med 324:212-218.
7. Flesch-Janys D, Steindorf K, Gurn P, Becher H. 1998. Estimation of the cumulated exposure to polychlorinated dibenzo-p-dioxins/furans and standardized mortality ratio analysis of cancer mortality by dose in an occupationally exposed cohort. Environ Health Perspect 106(suppl 2):665-662.
8. Hooiveld M, Heederik DJJ, Kogevinas M, Boffetta P, Needham LL, Patterson DG, Bueno-de-Mesquita HB. 1998. Second follow-up of a Dutch cohort occupationally exposed to phenoxy herbicides, chlorophenols, and contaminants. Am J Epidemiol 147:891-901.
9. Kodell RL, West RW. 1993. Upper confidence limits on excess risk for quantitative responses. Risk Anal 13:177-182.
10. Ott MG, Messerer P, Zober A. 1993. Assessment of past occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using blood lipid analyses. Int Arch Occup Environ Health 65:1-8.
11. Ott MG, Zober A. 1996. Cause specific mortality and cancer incidence among employees exposed to 2,3,7,8-TCDD after a 1953 reactor accident. Occup Environ Med 53:606-612.
12. Piacitelli LA, Sweeney MH, Fingerjut MA, Patterson DG Jr, Turner WE, Connally, LB, et al. 1992. Serum levels of PCDDs and PCDFs among workers exposed to 2,3,7,8-TCDD contaminated chemicals. Chemosphere 25:251-254.
13. Starr TB 2001. Significant shortcomings of the U.S. Environmental Protection Agency's latest draft risk characterization for dioxin-like compounds. Toxicol Sci 64:7-13.
14. Steenland K, Deddens J, Piacitelli L. 2001. Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on an epidemiologic study. Am J Epidemiol 154:451-458. [Published erratum: Am J Epidemiol 155:189 (2002).]
15. Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI. 1999. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst 91:779-786.
16. Tukey J, Ciminera J, Heyse J. 1985. The consultant's forum. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41:295-301.
17. U.S. EPA. 2000. Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds. Part III. Integrated Summary and Risk Characterization for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds. September 2000 SAB Review Draft. EPA/600/P-00/001Bg. Washington, DC:U.S. Environmental Protection Agency.
18. Van der Molen GW, Kooijman BALM, Wittspepe J, Schrey P, Flesch-Janys D, Slob W. 2000. Estimation of dioxin and furan elimination rates with a pharmacokinetic model. J Expo Anal Environ Epidemiol 10:579-585.
19. Venzon D, Moolgavkar S. 1988. A method for computing profile-likelihood-based confidence intervals. Appl Stat 37:87-94.
20. Zeilmaker MJ, van Eijkeren. 1998. The Calculation of Human Toxicity Thresholds of 2,3,7,8-TCDD: A Physiologically-Based Pharmacokinetic Modeling Approach. RIVM Report 601503.010. Bilthoven, the Netherlands:National Institute of Public Health and the Environment.